Form 8-K - Current report:
SEC Accession No. 0001062993-24-016208
Filing Date
2024-09-05
Accepted
2024-09-05 16:01:15
Documents
16
Period of Report
2024-08-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 26781
2 EXHIBIT 10.1 exhibit10-1.htm EX-10.1 22350
  Complete submission text file 0001062993-24-016208.txt   276470

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flgc-20240814.xsd EX-101.SCH 4687
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flgc-20240814_cal.xml EX-101.CAL 698
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flgc-20240814_def.xml EX-101.DEF 22562
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flgc-20240814_lab.xml EX-101.LAB 47263
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flgc-20240814_pre.xml EX-101.PRE 25251
19 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3286
Mailing Address 3230 W. COMMERCIAL BOULEVARD SUITE 180 FORT LAUDERDALE FL 33309
Business Address 3230 W. COMMERCIAL BOULEVARD SUITE 180 FORT LAUDERDALE FL 33309 416-861-2267
Flora Growth Corp. (Filer) CIK: 0001790169 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40397 | Film No.: 241281344
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)